Pharmacopeia

Canonical comparison

Master Compare

Compare candidate-facing canonical Pharmacopeia fields side by side. Isolated AI-draft proposals are never included.

2selected
Comparing 2 of 2 drugs
× ×
Change selection
2 drug columns · use arrows or scrollbar
Field PROPOFOL
Neurology & Sedation · Neurology & Sedation · Level 1
Midazolam
Neurology & Sedation · Neurology & Sedation · Level 1
Mechanism of action

selective modulation of GABA-A receptor (agonism)
(distinct from modulatory site for barbiturates and benzos, and GABA itself)
- Influx of Cl- into nerve cell
- Hyperpolarised, preventing conduction

increases the sensitivity GABAA receptors which open (via GABA) and allow Cl influx
causing hyperpolarisation
- Influx of Cl- into nerve cell
- Hyperpolarised, preventing conduction

Physiological effects

CNS: Sedation and hypnosis
(Rapid distribution across BBB)
No analgesia
Burst suppression
Decreases cerebral VO2, blood flow and ICP
CVS: signifi¬cant drop in BP due to decreased TPR, but without a reflex tachycardia (infusion
rate dependent)
Resp: Dose dependent resp depression, apnoea
GIT: Anti-emetic

CNS: Sedative, reduces epileptiform activity,
increases confusion and disorientation, amnesic properties more prominent than
sedative eff¬ects
CVS: minor hypotension has been reported

Resp: respiratory depression - synergistic with opioids

Absorption

A: onset / duration 30 seconds / 3-10 minutes

A : IV,PO,In,IM
poor oral bioavailability 45%

Distribution

pKa 11
very high lipid sol
Crosses placenta

lipid soluble at physiological pH (pKa 6.5).
high lipid sol crosses BBB

Protein binding

97-99%

Approximately 96% protein-bound in plasma.


Neurology & Sedation · Neurology & Sedation

highly protein bound (95%)


Neurology & Sedation · Neurology & Sedation

95%

Volume of distribution

2-10L/kg
60l/kg after 10 day infusion
↓ in elderly

Volume of distribution approximately 0.8-1.5 L/kg, increasing to about 3.1 L/kg in critically ill patients.


Neurology & Sedation · Neurology & Sedation

small-mod Vd = 1-2 L/kg
high lipid sol crosses BBB


Neurology & Sedation · Neurology & Sedation

1-2 L/kg

Metabolism

Hepatic to partially inactive metabolites (water soluble sulfate and glucuronide conjugates(~50%)
Clearance > liver blood flow, ∴extrahepatic metabolism

hepatic via CYP3A4, and glucuronidation
active metabolite

Excretion

Urine (~88% as metabolites,40% as glucuronide)

excreted in urine (as glucuronide conjugated metabolites)

Half-life

half life Biphasic: Initial 40 min; Terminal 4-7 hrs (up to 60hrs)

half life 1-4 hrs
prolonged in cirrhosis, CRF, CCF, obesity, elderly

Adverse Effects Toxicity

Hypotension (baroreceptor sens.
blunted, decreased sympathetic tone). Painful on injection.
Propofol syndrome: Metabolic acidosis, hyperlipidaemia, myocardial failure, death- common in children

Respiratory depression and excessive sedation with overdosage
Same CYP as alfentanil (increases effect)


Neurology & Sedation · Neurology & Sedation

Respiratory depression and excessive sedation with overdosage
Same CYP as alfentanil (increases e¬ffect)

Chemical Pharmaceutics —

- Imidazole ring in its structure - Accounts for water solubility And rapid metabolism
- 2-3x potent Diazepam

Class Group

Sedative / Hypnotic

Anticonvulsant Sedative-Hypnotic


Neurology & Sedation · Neurology & Sedation

Anticonvulsant
Sedative-Hypnotic


Neurology & Sedation · Neurology & Sedation

Sedative / Hypnotic

Indications Uses

Short term sedation
Induction and maintenance of anaesthesia
Maintenance of sedation

Sedative, amnesic+ anxiolytic,
antiepileptic

Introduction

2,6-di-isopropyl phenol Chemically inert phenolic derivative

- Benzodiazepine
- Imidazole ring in its structure - Accounts for water solubility And rapid metabolism
- 2-3x potent Diazepam

Legacy Cicm Level

Level 1

Level 1

Presentation

Milky white emulsion 1%
Soya bean lipid/Egg phosphatide
Sodium hydroxide
Weak org acid pKa 11- unionised

Clear solution pH 3.5 (IV/IM), Tablet
pKa 6.5 – 89% un-ionized

Route And Dose

Induction: 2-2.5mg/kg
Maintenance: 1-5mg/kg/hour
Both sig. less in critically ill

2-2.5mg initially then 1mg boluses to eff¬ect